glutathione cancer resistance metabolism in progression and treatment Depletion Stalwart Anticancer Activity of Metallotherapeutics Inducing Frontiers | Glutamine's double-edged sword:
Frontiers Glutamine's double edged sword: fueling tumor growth and offering therapeutic hope Glutathione S transferase Theta 2 causes drug resistance by inhibiting arsenic trioxide induced ferroptosis in pancreatic ductal adenocarcinoma ScienceDirect reduced glutathione and breast cancer Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score An illustration showing the role of GLRX5 suppression in predisposing Download Scientific Diagram
Pay in 4 interest-free payments of $6.97 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15



